Literature DB >> 17273490

Deciding on stimulant use for childhood ADHD: maintaining focus on the key questions.

John D McLennan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17273490      PMCID： PMC1781510     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  17 in total

1.  Medical and nonmedical stimulant use among adolescents: from sanctioned to unsanctioned use.

Authors:  C Poulin
Journal:  CMAJ       Date:  2001-10-16       Impact factor: 8.262

Review 2.  Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. American Academy of Pediatrics.

Authors: 
Journal:  Pediatrics       Date:  2000-05       Impact factor: 7.124

Review 3.  Management of stimulant medications in children with attention-deficit/hyperactivity disorder.

Authors:  A R Adesman; A M Morgan
Journal:  Pediatr Clin North Am       Date:  1999-10       Impact factor: 3.278

4.  Cost-effectiveness of ADHD treatments: findings from the multimodal treatment study of children with ADHD.

Authors:  Peter S Jensen; Joe Albert Garcia; Sherry Glied; Maura Crowe; Mike Foster; Michael Schlander; Stephen Hinshaw; Benedetto Vitiello; L Eugene Arnold; Glen Elliott; Lily Hechtman; Jeffrey H Newcorn; William E Pelham; James Swanson; Karen Wells
Journal:  Am J Psychiatry       Date:  2005-09       Impact factor: 18.112

5.  Stimulant treatment in young boys with symptoms suggesting childhood mania: a report from a longitudinal study.

Authors:  G A Carlson; J Loney; H Salisbury; J R Kramer; C Arthur
Journal:  J Child Adolesc Psychopharmacol       Date:  2000       Impact factor: 2.576

Review 6.  The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. Part I. Attention-Deficit/Hyperactivity Disorder.

Authors:  S R Pliszka; L L Greenhill; M L Crismon; A Sedillo; C Carlson; C K Conners; J T McCracken; J M Swanson; C W Hughes; M E Llana; M Lopez; M G Toprac
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2000-07       Impact factor: 8.829

7.  Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment.

Authors:  J M Swanson; H C Kraemer; S P Hinshaw; L E Arnold; C K Conners; H B Abikoff; W Clevenger; M Davies; G R Elliott; L L Greenhill; L Hechtman; B Hoza; P S Jensen; J S March; J H Newcorn; E B Owens; W E Pelham; E Schiller; J B Severe; S Simpson; B Vitiello; K Wells; T Wigal; M Wu
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2001-02       Impact factor: 8.829

8.  Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial.

Authors:  Cathryn A Galanter; Gabrielle A Carlson; Peter S Jensen; Laurence L Greenhill; Mark Davies; Wei Li; Shirley Z Chuang; Glen R Elliott; L Eugene Arnold; John S March; Lily Hechtman; William E Pelham; James M Swanson
Journal:  J Child Adolesc Psychopharmacol       Date:  2003       Impact factor: 2.576

9.  Implementing the American Academy of Pediatrics attention-deficit/hyperactivity disorder diagnostic guidelines in primary care settings.

Authors:  Laurel K Leslie; Jill Weckerly; Dena Plemmons; John Landsverk; Sarita Eastman
Journal:  Pediatrics       Date:  2004-07       Impact factor: 7.124

10.  Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment.

Authors:  Howard Abikoff; Lily Hechtman; Rachel G Klein; Gabrielle Weiss; Karen Fleiss; Joy Etcovitch; Lorne Cousins; Brian Greenfield; Diane Martin; Simcha Pollack
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2004-07       Impact factor: 8.829
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.